We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry.
Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience.
Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience.
Location: United Kingdom, Northern Ireland, Belfast
Total raised: $2.76M
Founded date: 2015
Investors 4
| Date | Name | Website |
| - | Par Equity | parequity.... |
| - | Angel CoFu... | acfinvesto... |
| - | Techstart ... | techstart.... |
| - | Co-FundNI | cofundni.c... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 13.07.2020 | - | $1.51M | Par Equity |
| 21.03.2017 | - | $1.25M | - |
Mentions in press and media 7
| Date | Title | Description |
| 21.07.2020 | BrainWaveBank Limited, an artificial intelligence (‘AI’) company focused on developing a machine learning-enabled neurocognitive platform for in-home assessment and remote monitoring of central nervou... | - |
| 15.07.2020 | Par Equity leads £1.2m funding round into Belfast based BrainWaveBank | We are excited to announce our continued support of Ronan Cunningham and the team at Belfast-based BrainWaveBank as they continue to scale their AI-based monitoring solution for Alzheimer’s and other neurological disorders. Read more here... |
| 13.07.2020 | Belfast-based BrainWaveBank raises €1.2 million to scale its AI-based monitoring solution for Alzheimer’s and depression | BrainWaveBank, an AI startup focused on developing a neurocognitive platform for in-home assessment and remote monitoring of central nervous system disorders, including neurodegenerative diseases such as Alzheimer’s, and psychiatric conditi... |
| 13.07.2020 | BrainWaveBank Raises £1.1M in Funding | BrainWaveBank Limited, a Belfast (UK) and Dublin (Ireland)-based provider of a neurocognitive platform that helps monitor diseases such as Alzheimer’s, and psychiatric conditions such as depression and schizophrenia, closed a £1.1m financin... |
| 21.03.2017 | BrainWaveBank Secures over £1M in Funding | BrainWaveBank, a Belfast, Northern Ireland-based UK healthtech startup, raised £1m in funding. The majority of the funding is equity-based, coming from Government-backed Angel CoFund, techstart NI, with Innovate UK and Invest Northern Irela... |
| 21.03.2017 | Belfast-based BrainWaveBank secures over £1 million in funding to tackle the early detection of dementia | BrainWaveBank, a health-tech startup that develops data-centric solutions for tracking brain health, has just secured over £1 million in funding from the Government-backed Angel CoFund, techstart NI, Innovate UK and Invest Northern Ireland ... |
| 21.03.2017 | Northern Ireland’s BrainWaveBank raises £1 million for its brain health tracking tech | Northern Irish health tech startup BrainWaveBank has raised investment of £1 million. Investors include Angel CoFund and techstart NI providing equity-based funding and Innovate UK and Invest Northern Ireland providing grants. BrainWaveBank... |